News

News
Partner news

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Read full story
Partner news

Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement

Read full story
JNJ Press releases

Gathering Innovation Strength to Capture New Value Johnson & Johnson is Recognized as the First Foreign-Funded Open Innovation Platform by the Shanghai Municipal Government

Read full story
Partner news

Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen

Read full story
Other news

ViaCyte Appoints Michael Yang President and CEO and Provides Company Update

Read full story
Other news

Paige Announces Series C Funding Round of $100 Million to Accelerate Transformation of Digital Pathology

Read full story
Partner news

£10 million research collaboration to detect lung cancer earlier

Read full story
Other news

4 Ways Johnson & Johnson Advanced Much-Needed Healthcare Innovations Amid the Pandemic

Read full story
Other news

Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines

Read full story
Partner news

Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform

Read full story
Partner news

Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program

Read full story
Other news

ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications

Read full story
Partner news

MacroGenics Enters Research Collaboration with Janssen to Develop Novel DART® Molecule

Read full story
Other news

XWPharma Names Michael M. Morrissey, PhD to Board of Directors

Read full story
Partner news

Australian National University Announces Research Project with Janssen to Help Develop New Methods for Measuring and Monitoring Type 1 Diabetes

Read full story